WREN THERAPEUTICS
Wren Therapeutics is a biopharmaceutical company based in Cambridge UK, focused on drug discovery and development for protein misfolding diseases, which include Alzheimer’s and Parkinson’s diseases, type-2 diabetes, and many rare forms of amyloidosis. Wren’s proprietary technology platform is built on new and fundamental understanding of the origins of these diseases and is based on decades of scientific research at the University of Cambridge and Lund University. Wren is using this platform to develop small molecule therapeutics for multiple protein misfolding diseases, including major neurological and rare disorders.
WREN THERAPEUTICS
Social Links:
Industry:
Biopharma Biotechnology Health Care Pharmaceutical
Founded:
2016-01-01
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.wrentherapeutics.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
40.28 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF WordPress Content Delivery Network Font Awesome Wordpress Plugins Nginx Sitelinks Search Box Euro
Current Advisors List
Current Employees Featured
Founder
Investors List
Lifeforce Capital
Lifeforce Capital investment in Venture Round - Wren Therapeutics
Industry Ventures
Industry Ventures investment in Venture Round - Wren Therapeutics
The Baupost Group
The Baupost Group investment in Venture Round - Wren Therapeutics
Schooner Capital
Schooner Capital investment in Venture Round - Wren Therapeutics
Lifeforce Capital
Lifeforce Capital investment in Series A - Wren Therapeutics
The Baupost Group
The Baupost Group investment in Series A - Wren Therapeutics
Malin Corporation
Malin Corporation investment in Funding Round - Wren Therapeutics
Official Site Inspections
http://www.wrentherapeutics.com Semrush global rank: 5.05 M Semrush visits lastest month: 1.64 K
- Host name: 172.67.149.157
- IP address: 172.67.149.157
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Wren Therapeutics"
Wren Therapeutics - Crunchbase Company Profile & Funding
Contact Email [email protected] Wren Therapeutics is a biopharmaceutical company based in Cambridge UK, focused on drug discovery and development for protein …See details»
WaveBreak (formerly Wren Therapeutics) Information
Wrentherapeutics.com; 1 659101XXXX; Janeta Popovici-Muller Senior Vice President, Head of Drug Discovery at WaveBreak (formerly Wren Therapeutics) Windham, NH, US View. 1 …See details»
Wren Therapeutics Ltd: Revenue, Worth, Valuation & Competitors …
About Wren Therapeutics Ltd. Wren Therapeutics Ltd is a Biotech related company founded in 2016 and based in Cambridge with 52 employees an estimated revenue of $4M, and. It has 10 …See details»
Wren Therapeutics - VentureRadar
"Wren Therapeutics, founded in 2016, is a spin-off company from the University of Cambridge (UK) and Lund University (Sweden). The company is based at the University of Cambridge, in …See details»
WREN THERAPEUTICS LIMITED - Companies House
WREN THERAPEUTICS LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business …See details»
Wren Therapeutics - Craft
Wren Therapeutics has 5 employees across 4 locations and $23.32 m in total funding,. See insights on Wren Therapeutics including office locations, competitors, revenue, financials, …See details»
Wren Therapeutics Ltd | LinkedIn
Wren Therapeutics Ltd | 1,738 followers on LinkedIn. Wren (www.wrentherapeutics.com) is a spin-off company from the University of Cambridge (UK) and Lund University (Sweden), …See details»
Wren Therapeutics (UK) Funding: $40.3M - medicalstartups.org
Apr 2, 2025 Wren Therapeutics is a biopharmaceutical company based, focused on drug discovery and development for protein misfolding...See details»
Wren Therapeutics Company Information - Funding, Investors, and …
Get information on funding, investors, industries, and more for Wren Therapeutics. See Wren Therapeutics company profile and funding data.See details»
Wren Appoints Bart Henderson as Chief Executive Officer
Mar 4, 2022 We are focusing this platform first on two of the greatest unmet medical needs of our time: Alzheimer’s disease and Parkinson’s disease. For more information, please visit …See details»
Wren Therapeutics secures £18 million in funding to tackle protein ...
Jan 25, 2019 Wren Therapeutics secures £18 million in funding to tackle protein misfolding diseases A biopharmaceutical company set-up by Cambridge academics from St John's …See details»
Wren Therapeutics - VentureRadar
Website: http://www.wrentherapeutics.com/ Develops innovative drug discovery approaches to address protein misfolding diseases, such as Alzheimer's, Parkinson's, and ...See details»
Wren Therapeutics - Overview, News & Competitors - ZoomInfo
View Wren Therapeutics (www.wrentherapeutics.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
Wren Therapeutics CEO and Key Executive Team | Craft.co
Wren Therapeutics's Chief Executive Officer, Director is Bart Henderson. Other executives include Samuel Cohen, Founder, Director; Michele Vendruscolo, Founder, Director and 6 …See details»
Wren Therapeutics - EU-Startups
Articles about Wren Therapeutics: January 29, 2021 Weekly VC Overview: All 66 European startup funding rounds we tracked this week (Jan 25-29, 2021); March 5, 2019 Procarta raises …See details»
Wren Therapeutics Company Information - Funding, Investors, and …
Https://wrentherapeutics.com. Wren Therapeutics is a biopharmaceutical company based, focused on drug discovery and development for protein misfolding diseases. Stay up to date with our …See details»
Wren raises £18M to drug protein-misfolding diseases
Jan 22, 2019 Wren Therapeutics has raised £18 million ($23 million). The British biotech will use the series A round to advance its research into drugs to treat protein-misfolding diseases such …See details»
Wren Taps Vertex Veteran Executives and Other Leaders to
Dec 8, 2022 We are focusing this platform first on some of the greatest unmet medical needs of our time: Parkinson’s disease, Alzheimer’s disease, and ALS. For more information, please …See details»
Wren Therapeutics - VentureRadar
Similar Companies: Origami Therapeutics USA Privately Held Origami Therapeutics, Inc. is a biotech company developing novel protein degraders with potential to delay or halt disease …See details»
Wren Taps Vertex Veteran Executives and Other Leaders to …
Dec 8, 2022 For more information, please visit: www.wrentherapeutics.com. Contact: Mary Moynihan M2Friend Biocommunications +1 (802) 951-9600 [email protected] SOURCE Wren …See details»